Status:
WITHDRAWN
To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis
Lead Sponsor:
Fougera Pharmaceuticals Inc.
Conditions:
Plaque Psoriasis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The aim of this trial is to assess the efficacy of NYC-0462 Ointment in the Treatment of Plaque Psoriasis.Treatment medication will be administered as follows: A thin layer of study product will be ap...
Eligibility Criteria
Inclusion
- Diagnosis of stable, symptomatic plaque psoriasis
- Good health with the exception of psoriasis
- % BSA and plaque elevation requirements
Exclusion
- Subjects who are pregnant, nursing or planning a pregnancy within the study participation period.
- Subjects who have any systemic or dermatological disorders with the exception of psoriasis
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00747032
Start Date
September 1 2010
End Date
April 1 2011
Last Update
May 7 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.